Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in kidney transplant recipients with diabetes mellitus

被引：0
|
作者：
Buckley, Sophieanne [1 ]
Subramaniam, Yuvanaa [1 ,2 ]
Mallik, Ritwika [1 ,3 ]
Mukuba, Dorcas [1 ]
Casabar, Mahalia [4 ]
Ali, Omer [4 ]
Byrne, Connor [4 ]
Chowdhury, Tahseen A. [1 ]
机构：
[1] Royal London Hosp, Dept Diabet & Metab, 7th Floor,John Harrison House,Whitechapel, London E1 1BB, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Diabet & Metab, London, England
[3] UCL, Ctr Obes Res, London, England
[4] Royal London Hosp, Dept Nephrol, London, England
来源：
DIABETIC MEDICINE | 2024年 / 41卷 / 08期
关键词：
D O I：
10.1111/dme.15383
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Sodium-glucose co-transporter-2 inhibitors : a potential cardioprotective agent?
    Stratinaki, M.
    Maragkoudakis, S.
    Stavrakis, S.
    Papoutsaki, E.
    Korela, D.
    Aletras, G.
    Honda, E.
    Garidas, G.
    Georgopoulou, T.
    Eleftheriadou, E.
    Pitarokoilis, M.
    Liapi, D.
    Kafkala, K.
    Foukarakis, E.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [32] Sodium-Glucose Cotransporter 2 Inhibitors in Kidney Transplant Recipients
    Lim, Jeong-Hoon
    Kwon, Soie
    Noh, Hee Won
    Jeon, Soojee
    Jung, Hee-Yeon
    Choi, Ji-Young
    Park, Sun-Hee
    Kim, Chan-Duck
    Kim, Yong-Lim
    Lee, Jung Pyo
    Cho, Jang-Hee
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 16 - 17
  • [33] SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR USE IN THE MANAGEMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES MELLITUS
    Alzetani, Sarah
    Suresh, Vijayan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I690 - I691
  • [34] Sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients-effectiveness and safety
    Freitas, Joana
    Silvano, Jose
    Ribeiro, Catarina
    Pedroso, Sofia
    Malheiro, Jorge
    Almeida, Manuela
    Fonseca, Isabel
    Martins, La Salete
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [35] Sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients-effectiveness and safety
    Freitas, Joana
    Silvano, Jose
    Ribeiro, Catarina
    Pedroso, Sofia
    Malheiro, Jorge
    Almeida, Manuela
    Fonseca, Isabel
    Martins, La Salete
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1691 - I1692
  • [36] Tolerability and efficacy of sodium-glucose co-transporter-2 inhibitors in Australian Aboriginal and Torres Strait Islanders with type 2 diabetes mellitus: an observational study
    Fishan, Noor
    Towers, Kurt
    Haurat, Javier
    Zimmermann, Anthony
    Radhakutty, Anjana
    INTERNAL MEDICINE JOURNAL, 2023, 53 (10) : 1916 - 1918
  • [37] Effects of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes in women versus men
    Radholm, Karin
    Zhou, Zien
    Clemens, Kristin
    Neal, Bruce
    Woodward, Mark
    DIABETES OBESITY & METABOLISM, 2020, 22 (02): : 263 - 266
  • [38] THE EFFICACY AND SAFETY CHARACTERISTICS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS IN KIDNEY TRANSPLANT RECIPIENTS: A META-ANALYSIS
    Boonpiraks, Kanachai
    Krisanapan, Pajaree
    Thongprayoon, Charat
    Cheungpasitporn, Wisit
    Anumas, Suthiya
    Pattharanitima, Pattharawin
    NEPHROLOGY, 2023, 28 : 77 - 78
  • [39] Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors
    Perelman, Moran Gvili
    Brzezinski, Rafael Y.
    Waissengrin, Barliz
    Leshem, Yasmin
    Bainhoren, Or
    Rubinstein, Tammi Arbel
    Perelman, Maxim
    Rozenbaum, Zach
    Havakuk, Ofer
    Topilsky, Yan
    Banai, Shmuel
    Wolf, Ido
    Laufer-Perl, Michal
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [40] Sodium-glucose co-transporter-2 inhibitors and cardiovascular outcome studies in people with type 2 diabetes: From efficacy to effectiveness
    Khunti, Kamlesh
    Kosiborod, Mikhail
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 763 - 765
12345